ALDH1A1 and non-small cell lung carcinoma: To determine whether cisplatin resistant NSCLC cells presenting with high ALDH1 activity are also enriched with tumorigenic properties, ALDH1+ve and ALDH1-ve cell subpopulations isolated from H460 cisplatin resistant cells were studied in a human xenograft mouse model using NOD/SCID mice.